BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 26965104)

  • 21. Icariin inhibits osteoclast differentiation and bone resorption by suppression of MAPKs/NF-κB regulated HIF-1α and PGE(2) synthesis.
    Hsieh TP; Sheu SY; Sun JS; Chen MH
    Phytomedicine; 2011 Jan; 18(2-3):176-85. PubMed ID: 20554188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Schisantherin A suppresses osteoclast formation and wear particle-induced osteolysis via modulating RANKL signaling pathways.
    He Y; Zhang Q; Shen Y; Chen X; Zhou F; Peng D
    Biochem Biophys Res Commun; 2014 Jul; 449(3):344-50. PubMed ID: 24845381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prevention of latanoprost on osteoclastgenesis in vitro and lipopolysaccharide-induced murine calvaria osteolysis in vivo.
    Xu X; Yan Y; Liu Z; Qi J; Qian N; Zhou H; Zhou Q; Wang T; Huang P; Guo L; Jiang M; Deng L
    J Cell Biochem; 2018 Jun; 119(6):4680-4691. PubMed ID: 29274286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypericin suppresses osteoclast formation and wear particle-induced osteolysis via modulating ERK signalling pathway.
    Ouyang Z; Zhai Z; Li H; Liu X; Qu X; Li X; Fan Q; Tang T; Qin A; Dai K
    Biochem Pharmacol; 2014 Aug; 90(3):276-87. PubMed ID: 24950468
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Herbacetin inhibits RANKL-mediated osteoclastogenesis in vitro and prevents inflammatory bone loss in vivo.
    Li L; Sapkota M; Kim SW; Soh Y
    Eur J Pharmacol; 2016 Apr; 777():17-25. PubMed ID: 26923730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alexidine Dihydrochloride Attenuates Osteoclast Formation and Bone Resorption and Protects Against LPS-Induced Osteolysis.
    Zhu X; Gao J; Ng PY; Qin A; Steer JH; Pavlos NJ; Zheng MH; Dong Y; Cheng TS
    J Bone Miner Res; 2016 Mar; 31(3):560-72. PubMed ID: 26363136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rhinacanthin C Inhibits Osteoclast Differentiation and Bone Resorption: Roles of TRAF6/TAK1/MAPKs/NF-κB/NFATc1 Signaling.
    Tomomura M; Suzuki R; Shirataki Y; Sakagami H; Tamura N; Tomomura A
    PLoS One; 2015; 10(6):e0130174. PubMed ID: 26083531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dehydrocostus lactone attenuates osteoclastogenesis and osteoclast-induced bone loss by modulating NF-κB signalling pathway.
    Hu B; Wu F; Shi Z; He B; Zhao X; Wu H; Yan S
    J Cell Mol Med; 2019 Aug; 23(8):5762-5770. PubMed ID: 31225720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Astragalus polysaccharide attenuates LPS-related inflammatory osteolysis by suppressing osteoclastogenesis by reducing the MAPK signalling pathway.
    Yang J; Qin L; Huang J; Li Y; Xu S; Wang H; Zhu S; Wang J; Zhu B; Li F; Huang W; Gong X; Hu N
    J Cell Mol Med; 2021 Jul; 25(14):6800-6814. PubMed ID: 34080298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Picroside II Inhibits RANKL-Mediated Osteoclastogenesis by Attenuating the NF-κB and MAPKs Signaling Pathway In Vitro and Prevents Bone Loss in Lipopolysaccharide Treatment Mice.
    Yang X; Gao W; Wang B; Wang X; Guo H; Xiao Y; Kong L; Hao D
    J Cell Biochem; 2017 Dec; 118(12):4479-4486. PubMed ID: 28464271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipopolysaccharide (LPS) promotes osteoclast differentiation and activation by enhancing the MAPK pathway and COX-2 expression in RAW264.7 cells.
    Hou GQ; Guo C; Song GH; Fang N; Fan WJ; Chen XD; Yuan L; Wang ZQ
    Int J Mol Med; 2013 Aug; 32(2):503-10. PubMed ID: 23740407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of sinomenine upon mesenchymal stem cells in osteoclastogenesis.
    Zhou B; Lu X; Tang Z; Liu D; Zhou Y; Zeng P; Xiong H
    Biomed Pharmacother; 2017 Jun; 90():835-841. PubMed ID: 28437887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Taxifolin Inhibits Receptor Activator of NF-κB Ligand-Induced Osteoclastogenesis of Human Bone Marrow-Derived Macrophages in vitro and Prevents Lipopolysaccharide-Induced Bone Loss in vivo.
    Zhang HQ; Wang YJ; Yang GT; Gao QL; Tang MX
    Pharmacology; 2019; 103(1-2):101-109. PubMed ID: 30522105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carnosol suppresses RANKL-induced osteoclastogenesis and attenuates titanium particles-induced osteolysis.
    Li Y; Lin S; Liu P; Huang J; Qiu J; Wen Z; Yuan J; Qiu H; Liu Y; Liu Q; Zhou T; Luo P; Guo H; Ma Y; Guo D; Mo G; Tang Y; Xu L; Liang D; Xu J; Ding Y; Zhang S
    J Cell Physiol; 2021 Mar; 236(3):1950-1966. PubMed ID: 32722851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitory effects of ursolic acid on osteoclastogenesis and titanium particle-induced osteolysis are mediated primarily via suppression of NF-κB signaling.
    Jiang C; Xiao F; Gu X; Zhai Z; Liu X; Wang W; Tang T; Wang Y; Zhu Z; Dai K; Qin A; Wang J
    Biochimie; 2015 Apr; 111():107-18. PubMed ID: 25681755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The inhibition of RANKL-induced osteoclastogenesis through the suppression of p38 signaling pathway by naringenin and attenuation of titanium-particle-induced osteolysis.
    Wang W; Wu C; Tian B; Liu X; Zhai Z; Qu X; Jiang C; Ouyang Z; Mao Y; Tang T; Qin A; Zhu Z
    Int J Mol Sci; 2014 Nov; 15(12):21913-34. PubMed ID: 25464380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Euscaphic acid isolated from roots of Rosa rugosa inhibits LPS-induced inflammatory responses via TLR4-mediated NF-κB inactivation in RAW 264.7 macrophages.
    Kim IT; Ryu S; Shin JS; Choi JH; Park HJ; Lee KT
    J Cell Biochem; 2012 Jun; 113(6):1936-46. PubMed ID: 22234926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epothilone B prevents lipopolysaccharide-induced inflammatory osteolysis through suppressing osteoclastogenesis via STAT3 signaling pathway.
    Chen Y; Wang Y; Hu J; Tang Y; Tian Z; Hu W; Zeng F; Tan J; Dai Q; Hou Z; Luo F; Xu J; Dong S
    Aging (Albany NY); 2020 Jun; 12(12):11698-11716. PubMed ID: 32527985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sinomenine regulates CD14/TLR4, JAK2/STAT3 pathway and calcium signal via α7nAChR to inhibit inflammation in LPS-stimulated macrophages.
    Zhu RL; Zhi YK; Yi L; Luo JF; Li J; Bai SS; Liu L; Wang PX; Zhou H; Dong Y
    Immunopharmacol Immunotoxicol; 2019 Feb; 41(1):172-177. PubMed ID: 30896303
    [No Abstract]   [Full Text] [Related]  

  • 40. Dendritic cells-derived interferon-λ1 ameliorated inflammatory bone destruction through inhibiting osteoclastogenesis.
    Chen Y; Wang Y; Tang R; Yang J; Dou C; Dong Y; Sun D; Zhang C; Zhang L; Tang Y; Dai Q; Luo F; Xu J; Dong S
    Cell Death Dis; 2020 Jun; 11(6):414. PubMed ID: 32488049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.